A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial

Published 2011 View Full Article

Authors

Keywords

Journal

CANADIAN JOURNAL OF CARDIOLOGY

Volume 25, Issue 9, Pages 509-515

Publisher

Elsevier BV

Online

2011-04-04

DOI

10.1016/s0828-282x(09)70136-9

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

CANADIAN JOURNAL OF CARDIOLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Become a Peeref-certified reviewer